儿童人群中磁共振胰胆管成像(MRCP)与内镜逆行胰胆管造影(ERCP)的诊断效能比较:一项临床有效性研究
该回顾性研究以ERCP为参考标准,评估MRCP在≤18岁儿童中检测胆胰管异常的诊断效能;54例患儿中,MRCP对任何异常的敏感度为76.8%、阳性预测值为81.7%,对胆道和胰腺异常分别为75.7%和73.5%敏感,假阴性和假阳性检查相对常见。
要点
- MRCP对儿童胆胰管任何异常的敏感度为76.8%(67.5-84.0%),阳性预测值为81.7%(72.7-88.3%)。
- MRCP对胆道异常敏感度75.7%(59.9-86.6%),对胰腺异常敏感度73.5%(59.7-83.8%)。
- MRCP对胰胆管联合异常的敏感度较高,达92.3%(66.7-99.6%)。
核心结论
- 在临床实践中,MRCP对胆道和胰腺异常具有中等敏感度,假阴性和假阳性检查相对常见。
研究设计与样本
- 回顾性研究,纳入2013年1月至2017年5月间在4周内同时接受ERCP和MRCP的≤18岁患者54例,以ERCP为参考标准。
诊断标准与关键数值
- 以ERCP为参考标准,MRCP检测任何异常(ERCP发现n=99)的敏感度为76.8%(67.5-84.0%),阳性预测值为81.7%(72.7-88.3%)。
- MRCP检测胆道异常(n=37)的敏感度为75.7%(59.9-86.6%),阳性预测值为84.9%(69.1-93.4%)。
- MRCP检测胰腺异常(n=49)的敏感度为73.5%(59.7-83.8%),阳性预测值为78.3%(64.4-87.7%)。
- MRCP检测胰胆管联合异常(n=13)的敏感度为92.3%(66.7-99.6%),阳性预测值为85.7%(60.1-97.5%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To determine the diagnostic performance of magnetic resonance cholangiopancreatography (MRCP) for detecting biliary and pancreatic abnormalities in a pediatric population, using endoscopic retrograde cholangiopancreatography (ERCP) as the reference standard.
MATERIALS AND METHODS: Institutional review board approval with a waiver of informed consent was obtained for this retrospective investigation. Records from the Cincinnati Children's Hospital Medical Center, Division of Gastroenterology and Department of Radiology were used to identify patients aged ≤ 18 years who had undergone both ERCP and MRCP within a 4-week interval between January 2013 and May 2017. Biliary and pancreatic duct findings were documented for each modality to determine the diagnostic performance of MRCP (with 95% confidence intervals), using ERCP as the reference standard.
RESULTS: 54 patients met inclusion criteria. Mean patient age at time of ERCP was 10.4 ± 4.9 years, and 25 (46%) were male. Mean interval between ERCP and MRCP was 11.2 ± 9.7 days. For detection of any abnormality (n = 99 ERCP findings), MRCP had a sensitivity of 76.8% (67.5-84.0%) and a positive predictive value (PPV) of 81.7% (72.7-88.3%). MRCP was 75.7% (59.9-86.6%) sensitive, with a PPV of 84.9% (69.1-93.4%) for biliary findings (n = 37) and 73.5% (59.7-83.8%) sensitive, with a PPV of 78.3% (64.4-87.7%) for pancreatic findings (n = 49). For pancreatobiliary abnormalities (n = 13), MRCP had a sensitivity of 92.3% (66.7-99.6%) and a PPV of 85.7% (60.1-97.5%).
CONCLUSION: In clinical practice, MRCP is moderately sensitive for biliary and pancreatic abnormalities, with false-negative and false-positive examinations being relatively common.
引用
- Dillman JR, Patel RM, Lin TK, et al. Diagnostic performance of magnetic resonance cholangiopancreatography (MRCP) versus endoscopic retrograde cholangiopancreatography (ERCP) in the pediatric population: a clinical effectiveness study. Abdom Radiol (NY). 2019. PMID: 30874847. doi:10.1007/s00261-019-01975-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。